Quantum company
Menten AI
Generative AI platform combining physics-based models and quantum simulations to design peptide macrocycle drugs.
Technology
Menten AI develops MAUD 1.0, a platform that designs peptide macrocycles for difficult drug targets by combining generative AI with physics-based models and quantum simulations. The company went through Y Combinator (Winter 2020) and raised a $4 million seed round in June 2020.
